Cargando…
Delineating the "galectin signature" of the tumor microenvironment
Galectins, a family of glycan-binding proteins, can control tumor progression by promoting transformation, angiogenesis and immune escape. We identified a dynamically regulated ‘galectin signature’, which delineates the progression of prostate cancer, highlighting galectin-1 as an attractive target...
Autores principales: | Compagno, Daniel, Laderach, Diego J., Gentilini, Lucas, Jaworski, Felipe M., Rabinovich, Gabriel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654582/ https://www.ncbi.nlm.nih.gov/pubmed/23734312 http://dx.doi.org/10.4161/onci.23565 |
Ejemplares similares
-
Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013) -
Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013) -
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
por: Tiraboschi, Carolina, et al.
Publicado: (2020) -
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
por: Gentilini, Lucas Daniel, et al.
Publicado: (2017) -
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
por: Croci, Diego O, et al.
Publicado: (2014)